Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report
Summary
Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Myriad Genetics, Inc. (Myriad or 'the company') is a molecular diagnostic company. The company is engaged in the development and marketing of novel predictive medicine, personalized medicine and prognostic medicine products. The company provides its products under Vectra, Endopredict, myRisk, Prequel, Foresight, MyChoice CDx, BRACAnalysis CDx, myPath, GeneSight, Prolaris, and brand names. It operates a CLIA-certified laboratory facility in Salt Lake City, Utah to perform most of the molecular diagnostic tests; a CLIA-certified laboratory in South San Francisco, California; a single laboratory facility in Munich, Germany to perform the international molecular diagnostic tests; and a CLIA-certified laboratory facility in Austin, Texas. The company has operations in the US and Europe. Myriad is headquartered in Salt Lake City, Utah, the US
Scope
- Detailed information on Myriad Genetics, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Myriad Genetics, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Myriad Genetics, Inc. including a breakdown and examination of key business segments
- Intelligence on Myriad Genetics, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Myriad Genetics, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of Myriad Genetics, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Myriad Genetics, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Myriad Genetics, Inc.'s business structure, strategy and prospects.
- Company Snapshot
- Myriad Genetics, Inc.: Company Overview
- Myriad Genetics, Inc.: Overview and Key Facts
- Myriad Genetics, Inc.: Overview
- Myriad Genetics, Inc.: Key Facts
- Myriad Genetics, Inc.: Key Employees
- Myriad Genetics, Inc.: Key Employee Biographies
- Myriad Genetics, Inc.: Major Products and Services
- Myriad Genetics, Inc.: Company History
- Myriad Genetics, Inc.: Management Statement
- Myriad Genetics, Inc.: Locations and Subsidiaries
- Myriad Genetics, Inc.: Key Competitors
- Myriad Genetics, Inc.: Company Analysis
- Myriad Genetics, Inc.: Business Description
- Myriad Genetics, Inc.: SWOT Analysis
- Myriad Genetics, Inc.: SWOT Overview
- Myriad Genetics, Inc.: Strengths
- Myriad Genetics, Inc.: Weaknesses
- Myriad Genetics, Inc.: Opportunities
- Myriad Genetics, Inc.: Threats
- Myriad Genetics, Inc.: Corporate Financial Deals Activity
- Myriad Genetics, Inc.: Financial Deals Overview
- Myriad Genetics, Inc.: Targets and Partners
- Myriad Genetics, Inc.: Top Deals 2018 - 2022YTD*
- Myriad Genetics, Inc.: Advisors
- Myriad Genetics, Inc.: Top Legal Advisors
- Myriad Genetics, Inc.: Top Financial Advisors
- Myriad Genetics, Inc.: Mergers and Acquisitions
- Myriad Genetics, Inc.: Capital Raising
- Myriad Genetics, Inc.: Partnership
- Myriad Genetics, Inc.: Divestments
- Myriad Genetics, Inc.: Recent Developments
- Myriad Genetics, Inc.: News and Events Summary
- Myriad Genetics, Inc.: Corporate Governance
- Myriad Genetics, Inc.: Financial Deals
- Myriad Genetics, Inc.: Financial Performance
- Myriad Genetics, Inc.: Market Developments
- Myriad Genetics, Inc.: Regulatory and Legal Events
- Appendix
- Contact Us
- Methodology
- About MarketLine
- List of Tables
- Table 1: Myriad Genetics, Inc.: Key Facts
- Table 2: Myriad Genetics, Inc.: Key Employees
- Table 3: Myriad Genetics, Inc.: Company History
- Table 4: Myriad Genetics, Inc.: Locations and Subsidiaries
- Table 5: Myriad Genetics, Inc.: Key Competitors
- Table 6: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Table 7: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
- Table 8: Myriad Genetics, Inc.: M&A Average Deal Size - Value (US$m)
- Table 9: Myriad Genetics, Inc.: Targets and Partners
- Table 10: Myriad Genetics, Inc.: Top Deals 2018 - 2022YTD*
- Table 11: Myriad Genetics, Inc.: Legal Advisor Ranking by Value (US$m)
- Table 12: Myriad Genetics, Inc.: Financial Advisor Ranking by Value (US$m)
- Table 13: Myriad Genetics, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
- Table 14: Myriad Genetics, Inc.: M&A Activity by Geography (2018 - YTD*2022)
- Table 15: Myriad Genetics, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
- Table 16: Myriad Genetics, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
- Table 17: Myriad Genetics, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
- Table 18: Myriad Genetics, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
- Table 19: Myriad Genetics, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
- Table 20: Myriad Genetics, Inc.: Divestments by Geography (2018 - YTD*2022)
- Table 21: Myriad Genetics, Inc.: News and Events Summary
- Table 22: Myriad Genetics, Inc.: Corporate Governance
- Table 23: Myriad Genetics, Inc.: Financial Deals
- Table 24: Myriad Genetics, Inc.: Financial Performance
- Table 25: Myriad Genetics, Inc.: Market Developments
- Table 26: Myriad Genetics, Inc.: Regulatory and Legal Events
- List of Figures
- Figure 1: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
- Figure 3: Myriad Genetics, Inc.: M&A Average Deal Size - Value (US$m)
- Figure 4: Myriad Genetics, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
- Figure 5: Myriad Genetics, Inc.: M&A Activity by Geography (2018 - YTD*2022)
- Figure 6: Myriad Genetics, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
- Figure 7: Myriad Genetics, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
- Figure 8: Myriad Genetics, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
- Figure 9: Myriad Genetics, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
- Figure 10: Myriad Genetics, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
- Figure 11: Myriad Genetics, Inc.: Divestments by Geography (2018 - YTD*2022)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook